Monday 12th September 2022 |
Text too small? |
Synlait Milk Limited (Synlait) provides an update on the re-registration process for its State Administration for Market Regulation (SAMR) licence for The a2 Milk Company’s Chinese labelled 至初® Infant Formula.
Synlait has received notification from SAMR that the company’s current registration has been renewed. The renewal allows Synlait to manufacture Chinese labelled 至初® Infant Formula until 21 February 2023 under the previous GB standard.
In parallel, Synlait is working towards achieving its re-registration under the new GB (food safety legislation). The new GB recipe registration timeline and process has been impacted by China’s COVID-19 lockdowns.
Synlait is working with The a2 Milk Company on stock transition plans. Synlait does not anticipate current forecasted volumes of China-label a2 Platinum® Infant Formula to be impacted by changes to the re-registration timetable. Positive and constructive engagement with SAMR officials is ongoing.
Synlait CEO Grant Watson commented: “We are very pleased SAMR has renewed our current China registration. Gaining re-registration for the new GB recipe is a top priority for Synlait and The a2 Milk Company.”
Announcement: Synlait provides SAMR update; current registration renewed
No comments yet
AIA - Auckland Airport considers bond offers
September 22nd Morning Report
September 19th Morning Report
Smartpay Scheme Booklet and Notice of Meeting
September 18th Morning Report
Seeka Increases Forecast Full Year Earnings Guidance
TEM - Ability to invest in derivatives
Devon Funds Morning Note - 16 September 2025
September 17th Morning Report
MPG - Recapitalisation Closes Oversubscribed, Raises $23.9m